No Data
No Data
Some Confidence Is Lacking In Medlive Technology Co., Ltd.'s (HKG:2192) P/E
MEDLIVE: INTERIM REPORT 2024
If EPS Growth Is Important To You, Medlive Technology (HKG:2192) Presents An Opportunity
Medlive Technology Co., Ltd. Just Recorded A 32% EPS Beat: Here's What Analysts Are Forecasting Next
Medlive Technology Declares Interim Dividend
【HK Stock Connect】 iFlytek (02192) recorded a 48.62% increase in interim profit and declared an interim dividend of RMB 0.1205.
Kingold Financial News | Yimai Tong (02192) announced the interim performance for the six months ended June 30, 2024, recording a profit attributable to owners of the parent company of 0.147 billion yuan (RMB, the same below), a year-on-year increase of 48.62%, with basic earnings per share of 20.18 cents. It plans to distribute an interim dividend of HK$0.1205 per share. During the period, the Group's revenue was 0.243 billion yuan, a year-on-year increase of 40.31%; gross profit was 0.147 billion yuan, a year-on-year increase of 40.02%. Among them, revenue from precision marketing and enterprise solutions was 0.226 billion yuan, a year-on-year increase of 42.7%; medical knowledge solutions
No Data
No Data
冷暖自知 : Very good return, long term or short term?